Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hills

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 8, 2024
TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylateMaría Patricia Hernández-Mitre, Susan C Morpeth, Balasubramanian Venkatesh, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 9, 2024
Erratum to 'TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate' [Clin Microbiol Infect (30) (2024) 743-754]María Patricia Hernández-Mitre, Susan C Morpeth, Balasubramanian Venkatesh, et al.
Clinical Pharmacokinetics|August 30, 2022
Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative ReviewMaría Patricia Hernández-Mitre, Steven Y C Tong, Justin T Denholm, et al.
Biomolecules|November 27, 2025
A Novel Role of Hyaluronan and Its Membrane Receptors, CD44 and RHAMM, in Obesity-Related Kidney PathologyBingxue Qi, Vishal Musale, Xiong Weng, et al.
The Annals of Pharmacotherapy|August 28, 2024
Antibiotic De-Escalation Practices in the Intensive Care Unit: A Multicenter Observational StudyAsad E Patanwala, Arwa Abu Sardaneh, Jan-Willem C Alffenaar, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 27, 2025
Research recommendations from the 2024 Breakthrough T1D, Diabetes UK and Kidney Research UK, diabetes and kidney disease expert workshopZoe Markham-Lee, Swati Bhagat-Jones, Jill Carlton, et al.
Applied Optics|August 22, 2008
South Pole Telescope opticsS Padin, Z Staniszewski, R Keisler, et al.
The New England Journal of Medicine|February 25, 2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19, Anthony C Gordon, Paul R Mouncey, et al.
Intensive Care Medicine|July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trialYaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
NEJM Evidence|February 6, 2024
A Randomized Trial of Nafamostat for Covid-19Susan C Morpeth, Balasubramanian Venkatesh, James A Totterdell, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 8, 2024
TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylateMaría Patricia Hernández-Mitre, Susan C Morpeth, Balasubramanian Venkatesh, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 9, 2024
Erratum to 'TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate' [Clin Microbiol Infect (30) (2024) 743-754]María Patricia Hernández-Mitre, Susan C Morpeth, Balasubramanian Venkatesh, et al.
Clinical Pharmacokinetics|August 30, 2022
Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative ReviewMaría Patricia Hernández-Mitre, Steven Y C Tong, Justin T Denholm, et al.
Biomolecules|November 27, 2025
A Novel Role of Hyaluronan and Its Membrane Receptors, CD44 and RHAMM, in Obesity-Related Kidney PathologyBingxue Qi, Vishal Musale, Xiong Weng, et al.
The Annals of Pharmacotherapy|August 28, 2024
Antibiotic De-Escalation Practices in the Intensive Care Unit: A Multicenter Observational StudyAsad E Patanwala, Arwa Abu Sardaneh, Jan-Willem C Alffenaar, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 27, 2025
Research recommendations from the 2024 Breakthrough T1D, Diabetes UK and Kidney Research UK, diabetes and kidney disease expert workshopZoe Markham-Lee, Swati Bhagat-Jones, Jill Carlton, et al.
Applied Optics|August 22, 2008
South Pole Telescope opticsS Padin, Z Staniszewski, R Keisler, et al.
The New England Journal of Medicine|February 25, 2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19, Anthony C Gordon, Paul R Mouncey, et al.
Intensive Care Medicine|July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trialYaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
NEJM Evidence|February 6, 2024
A Randomized Trial of Nafamostat for Covid-19Susan C Morpeth, Balasubramanian Venkatesh, James A Totterdell, et al.
Pageof 14